In the US, nearly 95,000 patients are waitlisted for a kidney transplant, yet in 2018, only 14,700 received a deceased donor kidney transplant, while nearly 8,500 died or became too sick. The organ shortage is equally intense for liver transplant; in 2018, among more than 14,000 waitlisted patients, only 7,700 received a deceased donor liver transplant while 2,500 died or became too sick. Unfortunately, more than 5,000 kidneys and 2,000 livers from deceased donors were offered for transplant in 2018, but never transplanted. Although a subset of these organs was unsuitable for transplant, data clearly demonstrate that the inability to accurately assess graft quality directly led to many discards and/or undermined our ability to guide organs to appropriate patients. Prior to their organs being offered for transplant, deceased donors are hospitalized for days, often with numerous longitudinal data points (e.g., laboratory values) available to assess organ function. Yet, existing models of graft quality have these major flaws: 1) a reliance on cross-sectional clinical and laboratory data directly prior to procurement; 2) neglect of biologically-relevant, longitudinal data from the donor terminal hospitalization such serial hemodynamics (kidney and liver) and urine output (kidney); and 3) failure to integrate interactions between donor and recipient characteristics. As a result, existing kidney and liver donor risk models have inadequate prediction accuracy (C-statistics of only 0.6-0.65). Our group proposes to advance the field by developing state-of-the art models that make use of extensive, longitudinal donor data during the donor's terminal hospitalization?laboratory biomarkers of organ injury, and measures of organ function and perfusion. Second, we will develop highly robust allograft risk models using the joint modeling approach, which can account for longitudinal donor exposure data and time-to-event outcomes such as graft failure, instead of standard techniques (e.g., Cox regression). Third, we will highlight the real-world impact of the results in terms of population health. We have these specific aims: 1) Develop kidney graft failure models using joint modeling to predict graft failure with higher discrimination and calibration relative to the current kidney donor risk index; 2) Develop liver graft failure risk models using joint modeling to predict graft failure with high discrimination and calibration; 3a) Simulate the change in allograft life years from better pairing organs to recipients based on alignment of projected organ and patient survival; and 3b) Simulate the change in the number of transplants and allograft life years for the transplant population by implementing improved organ quality metrics in organ allocation to decrease discards. The models will be constructed using comprehensive US transplant data and externally validated with data from two Canadian provinces. The grant will also include important exploratory analyses of transplant complications by linking to data from Medicare. We will finally develop a web-based tool to enable real-time predictions of organ outcomes to put the results in the hands of clinicians and other investigators.
In 2018, more than 7,000 kidneys and livers from deceased donors were discarded or never recovered, despite the serious public health issue that more than 11,000 patients waitlisted for a kidney or liver transplant died or became too sick to transplant. Transplant professionals lack tools to accurately assess organ quality, which directly led to many of these discards and undermined our ability to guide the right organs to appropriate patients. This work seeks to use longitudinal data and novel statistical methodologies to dramatically improve our ability to assess graft quality and thereby increase the number of lifesaving transplants.
